Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerium nitrate + silver sulfadiazine versus silver sulfadiazine alone for deep second-degree burn wound healing
IRCT20180609040016N8Phase 3Recruiting
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of silver sulfadiazine in burn injury (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Burn cause, Age and 2 more. Started Aug 2026; status: recruiting.
02
Drugs
silver sulfadiazine
03
Conditions
burn injury
Beyond the preview
Go deeper on IRCT20180609040016N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180609040016N8.